--- title: Buy Daclatasvir 60mg Pills Online description: Daclatasvir 60mg Pills are used in combination therapy for chronic hepatitis C virus infection. Order this trusted antiviral medication online for reliable delivery and verified quality. type: product language: en url: https://liabilis.com/order-daclatasvir-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 513.94 price_max: 867.34 currency: USD offers: - name: 60mg x 28 pills price: 513.94 - name: 60mg x 56 pills price: 867.34 --- # Buy Daclatasvir 60mg Pills Online Daclatasvir is a direct-acting antiviral medication used in combination regimens to treat chronic hepatitis C virus infection. It works by inhibiting the NS5A protein, preventing viral replication. This medication is prescribed for adults with specific genotypes of the hepatitis C virus to achieve sustained virologic response. Our pharmacy provides convenient access to Daclatasvir in 60mg pills from reliable sources. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **60mg** | 28 pills | **$513.94** | $18.35 | In Stock | | **60mg** | 56 pills | **$867.34** | $15.48 | In Stock | [Buy Now](https://liabilis.com/order-daclatasvir-online-en.html) ## Introduction Daclatasvir is a generic antiviral medication used to treat chronic hepatitis C virus (HCV) infection. The active ingredient is daclatasvir, supplied in a 60 mg oral tablet. Classified as an NS5A inhibitor, it blocks a viral protein essential for HCV replication. Daclatasvir is typically prescribed as part of combination therapy with other direct-acting antivirals, such as sofosbuvir, to achieve sustained virologic response across multiple HCV genotypes. It is approved for adult patients with compensated liver disease and provides an essential option for those seeking an effective, all-oral regimen. ## Quick Reference Facts **Active Ingredient** : Daclatasvir **Form** : pill 60 mg **Primary Uses** : Treatment of chronic hepatitis C infection (in combination with other antiviral agents) ## What is Daclatasvir? Daclatasvir belongs to the class of direct-acting antivirals (DAAs) that target the non-structural protein 5A (NS5A) of hepatitis C virus. The drug was originally developed by Bristol-Myers Squibb and marketed under the brand name Daklinza. As a generic product, daclatasvir is the same chemical entity and meets the same bioequivalence standards as the brand formulation, offering a comparable safety and efficacy profile at a lower cost. It is supplied as a 60 mg film-coated tablet taken once daily in combination with other DAAs to form a complete, interferon-free treatment regimen. ## How Daclatasvir Works NS5A is a multifunctional viral protein that coordinates HCV RNA replication and assembly of viral particles. Daclatasvir binds to a conserved region of NS5A, causing a conformational change that disrupts the formation of the replication complex. This inhibition halts production of new viral genomes and prevents the virus from assembling infectious particles. Because NS5A is essential across all major HCV genotypes, daclatasvir demonstrates pan-genotypic activity when paired with complementary agents such as sofosbuvir. The drug is metabolized primarily by CYP3A4 and is eliminated in feces; its half-life of approximately 15 hours supports once-daily dosing. ## Conditions Treated with Daclatasvir - **Chronic Hepatitis C Genotype 1, 2, 3, or 4 Infection** Daclatasvir, combined with sofosbuvir (with or without ribavirin), is approved for adult patients with compensated liver disease. The regimen achieves high cure rates (≥95 % sustained virologic response) across these genotypes. - **Hepatitis C Infection with Prior Treatment Failure** Patients who have not responded to earlier interferon-based or DAA regimens may receive daclatasvir-based therapy as a salvage option, provided they meet liver function criteria. - **Hepatitis C in Patients with Renal Impairment** When used in combination with sofosbuvir, daclatasvir is safe for patients with moderate renal dysfunction (eGFR ≥30 mL/min/1.73 m²). Dose adjustment is not required for the daclatasvir component. ## Is Daclatasvir the Right Medication for You? Daclatasvir is appropriate for adults with chronic HCV infection who have measurable viral load and no decompensated cirrhosis. It is especially suitable for patients who prefer an all-oral, interferon-free regimen and who can comply with daily dosing. Contraindications include known hypersensitivity to daclatasvir or any tablet excipients, and co-administration with strong CYP3A4 inducers such as rifampin, carbamazepine, or St. John’s wort, which markedly reduce drug exposure. Clinicians should evaluate liver function, potential drug-drug interactions, and HCV genotype before initiating therapy. ## Buying Daclatasvir from [our online pharmacy](https://liabilis.com/order-daclatasvir-online-en.html) ### Why Choose Our Service? Accessing antiviral therapy can be challenging due to high retail prices and limited local availability. Our pharmacy service delivers a reliable, cost-effective solution for patients who need daclatasvir but encounter barriers in traditional pharmacies. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every batch of daclatasvir is sourced from manufacturers that comply with Good Manufacturing Practice (GMP) standards and is verified by independent quality-control laboratories. ### Pricing & Access Because daclatasvir is available as a generic, the price through [our online pharmacy](https://liabilis.com/order-daclatasvir-online-en.html) is close to the manufacturer’s wholesale cost, offering substantial savings compared with brand-name equivalents. Our platform also facilitates delivery to regions where the medication may be scarce or subject to restrictive insurance formularies. ### Discreet Delivery Orders are packaged in unmarked, tamper-evident envelopes and dispatched via express couriers, typically arriving within 7 days to most destinations. Standard airmail is also available, with an expected delivery window of approximately three weeks. Your privacy is protected at every step of the process. ## Use: Dosing, Missed Dose, Overdose - **Standard Dosing** - One 60 mg tablet taken orally once daily, preferably with food to improve absorption. - The tablet should be swallowed whole; do not split, crush, or chew. - **Missed Dose** - If you realize a dose was missed within 12 hours, take it as soon as you remember. - If it is closer to the time of the next scheduled dose, skip the missed tablet and resume the regular schedule. Do not double-dose. - **Suspected Overdose** - Overdose is unlikely to be life-threatening, but you should seek medical attention promptly. - Supportive care, including observation and monitoring of hepatic function, is the standard approach. - **Practical Precautions** - Avoid concomitant use of strong CYP3A4 inducers, as they can reduce therapeutic levels. - Alcohol consumption does not directly interact with daclatasvir but may worsen liver disease; limit intake. - Operating heavy machinery is generally safe, but monitor for fatigue or dizziness, especially during the initial treatment weeks. ## Safety Information ### ⚠️ Who Should Not Take Daclatasvir - Patients with known hypersensitivity to daclatasvir or any tablet excipients. - Individuals receiving strong CYP3A4 inducers (e.g., rifampin, carbamazepine, St. John’s wort). - Persons with decompensated cirrhosis (Child-Pugh class B or C) unless specifically advised by a specialist. ### Common Side Effects - **Fatigue** - reported in up to 30 % of patients; usually mild and transient. - **Headache** - occurs in roughly 20 % of users; over-the-counter analgesics may help. - **Nausea or abdominal discomfort** - generally resolves within the first two weeks of therapy. ### Serious Side Effects (Seek Immediate Medical Help) - **Severe hepatic decompensation** - signs include jaundice, abdominal swelling, or sudden worsening of liver function. - **Hypersensitivity reactions** - rash, itching, swelling of the face or throat, or difficulty breathing. - **Elevated transaminases** - may indicate liver injury; monitor liver enzymes regularly. ### Drug & Food Interactions - **Strong CYP3A4 inducers** (rifampin, carbamazepine, phenytoin) ↓ daclatasvir levels → loss of efficacy. - **CYP3A4 inhibitors** (ketoconazole, darunavir) ↑ daclatasvir exposure → higher risk of side effects; dose adjustment may be required. - **Antacids containing aluminum or magnesium** - may reduce absorption; separate administration by at least 2 hours. - **Concurrent use with other DAAs** (e.g., ledipasvir) is safe when prescribed together, but unsupervised combinations are discouraged. ## Off-Label and Investigational Uses of Daclatasvir Some clinical investigations have explored daclatasvir for hepatitis C patients with severe renal impairment undergoing dialysis, showing comparable efficacy without dose modification. Small pilot studies have also examined its role in preventing HCV reinfection after liver transplantation, though results remain preliminary. Additionally, laboratory research suggests potential activity against other flaviviruses, but no clinical data support routine use. Off-label application should only be undertaken under the direct supervision of a qualified healthcare provider, as safety and effectiveness have not been formally approved by regulatory authorities. ## Storage & Handling - Store tablets at 20-25 °C (68-77 °F) in a dry place, protected from light and moisture. - Do not refrigerate or freeze. - Keep the container tightly closed and out of reach of children. - Discard any tablets that are discolored, broken, or past the expiration date. - For safe disposal, consult a pharmacy take-back program or follow local hazardous-waste guidelines. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with my daclatasvir tablets?** Yes. Carry the medication in its original packaging with a copy of the prescription or a physician’s letter, as some countries require documentation for antiviral drugs. - **Should I take daclatasvir at the same time each day?** Taking the tablet at a consistent time helps maintain steady blood levels and simplifies adherence, but exact timing is less critical than daily intake. - **Is it safe to drink coffee while on daclatasvir?** Moderate coffee consumption does not affect daclatasvir’s pharmacokinetics and is generally considered safe. - **Can I take vitamin supplements together with daclatasvir?** Most over-the-counter vitamins are compatible, but high-dose mineral supplements containing calcium or iron should be separated by at least two hours to avoid absorption issues. **Product & Formulation Details** - **What does a daclatasvir tablet look like?** The generic 60 mg tablet is typically white, film-coated, and round, with the imprint “60 MG”. Appearance may vary slightly between manufacturers. - **Are any inactive ingredients in the tablet likely to cause allergies?** Common excipients include lactose, magnesium stearate, and microcrystalline cellulose. Patients with lactose intolerance or specific excipient allergies should review the full ingredient list with their pharmacist. **Regulatory & Safety Nuances** - **Will daclatasvir show up on a standard drug test?** Daclatasvir is not part of routine occupational or sports drug-screening panels, as it is an antiviral, not a performance-enhancing or controlled substance. - **Can I obtain daclatasvir without a prescription in my country?** Regulations vary; in most jurisdictions, daclatasvir requires a physician’s prescription. Importing it without proper authorization may violate local laws. - **Is daclatasvir safe for elderly patients?** Clinical trials included participants up to 75 years old and did not reveal age-specific safety concerns, though liver function should be evaluated before treatment. **Scientific & Clinical Curiosity** - **What was the key clinical trial that led to daclatasvir’s approval?** The Phase III ION-3 trial demonstrated >95 % sustained virologic response when daclatasvir was combined with sofosbuvir for 12 weeks in genotype 1 patients, forming the basis for regulatory approval- **How does daclatasvir differ from other NS5A inhibitors?** Daclatasvir has a high barrier to resistance and a longer half-life compared with earlier NS5A agents, allowing once-daily dosing and broader genotype coverage. ## Glossary **NS5A Inhibitor** : A class of antiviral drugs that block the hepatitis C virus NS5A protein, essential for viral replication and assembly. **Sustained Virologic Response (SVR)** : The absence of detectable HCV RNA in the blood 12 weeks after completing therapy, regarded as a cure. **CYP3A4** : A liver enzyme that metabolizes many drugs; substances that induce or inhibit CYP3A4 can alter the levels of medications like daclatasvir. **Compensated Cirrhosis** : Advanced liver scarring where the liver still performs essential functions without clinical signs of failure. ## Disclaimer The material presented about **Daclatasvir** is intended solely for general educational purposes and does not substitute personalized medical counsel. All therapeutic choices, including those involving off-label applications, must be made in collaboration with a qualified healthcare professional. Readers are presumed to be mature adults capable of making informed health decisions. [our online pharmacy](https://liabilis.com/order-daclatasvir-online-en.html) supplies Daclatasvir to individuals who may encounter limited availability, insurance barriers, or who are seeking cost-effective generic alternatives. Prior to initiating, modifying, or discontinuing any medication, you should seek guidance from your physician.